News

Here are some things to check out in the city while you're in town...

It’s time for psychiatry to address the crisis at the border.

What movies are you watching this weekend?

Pain is escalating…

Brexpiprazole has been approved by the US Food and Drug Administration for the treatment of agitation associated with Alzheimer disease dementia.

Psychiatric Times® salutes our armed forces and remembers those who have fallen during service.

See you in San Francisco!

Study investigates connections between rTMS and factors including depression and cognitive performance.

An expert discusses the reality of and the true role of psychiatrists in involuntary hospitalization.

Ketamine is relatively new to the average American. What can you share with them as a mental health clinician?

The United States versus Great Britain…

“As we attempt to confront the legacy of American classism and racism, we in the medical profession must confront the ways that our own institutions unwittingly continue to reflect and mirror broader social realities.”

"I have autism. All my friends say so. I do have autism. You just don't get it."

What does artificial intelligence have to say about preventing anti-Semitism?

From new FDA treatment approvals to choosing the right levels of care in crisis stabilization units, here are highlights from the week in Psychiatric Times.

How can the response of "oh veh" to mayday help us with recovery and resilience?

Chip on your shoulder?

Here’s how having a clear understanding of the services different crisis stabilization units provide can help communities serve the unique needs of each individual in crisis without unnecessarily restrictive or intensive levels of care.

When considering transcranial magnetic stimulation as a treatment option for treatment-resistant depression, here are some key questions to ask the patient.

A mayday call to support maternal mental health.

First of its kind culturally sensitive adherence scale factors in CVD risk factors to find ways to best support patients.

What is wisdom, and how is it connected to age?

When the Surgeon General notices the loneliness problem, it is definitely a mayday moment.

The risperidone formulation is the first FDA-approved treatment for this patient population to use technology enabling controlled release over time.

Treatment is now the first and only once-at-bedtime oxybate to be approved by the FDA for individuals with narcolepsy.

What lessons can we learn from May Day, mayday, and rejection?

May is Mental Health Month!

The experts weighed in on a wide variety of psychiatric issues for the April 2023 issue of Psychiatric Times.

"life, liberty, and happiness pursue survival hanging in the distance..."